8-K
PetMed Express Amends 2024 Inducement Incentive Plan and Increases Reserved Shares
8-K
PetMeds Appoints Tamar Elkeles as New Independent Director and Chair of the Compensation and Human Capital Committee
8-K
PetMeds Appoints Jeff Willard as CEO and President, Announces Board Leadership Transition
8-K
PetMeds® Announces First Quarter Fiscal 2027 Financial Results
8-K
PetMed Express, Inc. Announces Results of 2026 Annual Meeting of Shareholders
8-K
PetMeds Announces Proposed $37 Million Sale-Leaseback of Headquarters and Distribution Center
